Robust validation studies suggest potent clinical efficacy

Engineered Treg cells have been stress tested in various conditions:

Proven effective in:

Triple Negative Breast Cancer

Prostate Cancer

Glioblastoma

Pancreatic Cancer

Impressive and consistent
preclinical efficacy